| Market Cap | ₹14,338Cr |
| ROE | 17.73% |
| P/E Ratio(TTM) | 44.33 |
| EPS(TTM) | 30.92 |
| P/B Ratio | 7.85 |
| Dividend Yield | 0.64% |
| Industry P/E | 33.29 |
| Book Value | 174.68 |
| Debt to Equity | 0.00 |
| Face Value | 1 |
| Parent Organisation | Concord Biotech |
| Managing Director | Mr. Ankur Vaid |
| NSE Symbol | CONCORDBIO |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 39.25 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 33.30 | ||
| Wockhardt | NA (0.00%) | -427.29 | ||
| Cohance Lifesciences | NA (0.00%) | 65.51 |